(Q34455267)

2 August 2017

Clozapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation (English)

1 reference

2 August 2017

0 references

Rollema H

1

1 reference

2 August 2017

Lu Y

series ordinal

2

1 reference

2 August 2017

Schmidt AW

series ordinal

3

1 reference

2 August 2017

Zorn SH

series ordinal

4

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 November 1997

1 reference

European Journal of Pharmacology

2 August 2017

1 reference

2 August 2017

338

1 reference

2 August 2017

R3-5

1 reference

2 August 2017

2

1 reference

Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981951-6

Clozapine is a partial agonist at cloned, human serotonin 5-HT1A receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981951-6

Regulation of prefrontal cortical dopamine release by dopamine receptor agonists and antagonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981951-6

Ipsapirone enhances the dopamine outflow via 5-HT1A receptors in the rat prefrontal cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981951-6

Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981951-6

Clozapine is a potent and selective muscarinic M4 receptor agonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2981951-6

10.1016/S0014-2999(97)81951-6

7 January 2021

Identifiers

DOI

1 reference

2 August 2017

1 reference